97-29072. Notice of Availability of Environmental Assessment and Finding of No Significant Impact for Actions to be Taken Under the NIH Guidelines for Research Involving Recombinant DNA Molecules  

  • [Federal Register Volume 62, Number 213 (Tuesday, November 4, 1997)]
    [Notices]
    [Page 59720]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-29072]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    Notice of Availability of Environmental Assessment and Finding of 
    No Significant Impact for Actions to be Taken Under the NIH Guidelines 
    for Research Involving Recombinant DNA Molecules
    
        Notice is hereby given of the availability of an Environmental 
    Assessment (EA) and Finding of No Significant Impact (FONSI) for public 
    review. The EA is for actions to be taken under the NIH Guidelines for 
    Research Involving Recombinant DNA Molecules (59 FR 34496, amended 59 
    FR 40170, 60 FR 20726, 61 FR 1482, 61 FR 10004, 62 FR 4782). Under the 
    actions, the National Institutes of Health (NIH) will relinquish its 
    approval of individual human gene transfer protocols to the Food and 
    Drug Administration, which has statutory authority for such approvals. 
    Instead, the NIH will emphasize its role as the focal point for policy 
    discussion and review of scientific, safety, social, and ethical issues 
    arising from human gene transfer research. The EA finds that these 
    actions will not significantly affect the quality of the human 
    environment.
        Copies of the EA and FONSI can be viewed in the NIH Environmental 
    Reading Room, Building 31, Room 2B04, 9000 Rockville Pike, Bethesda, MD 
    20892. Additional copies of the EA and FONSI are available for viewing 
    in the NIH Office of Recombinant DNA Activities (ORDA), 6000 Executive 
    Boulevard, Suite 302, Bethesda, MD 20892-7010.
        For further information, contact Debra Knorr, Deputy Director, 
    Office of Recombinant DNA Activities, National Institutes of Health, 
    MSC 7010, 6000 Executive Boulevard, Suite 302, Bethesda, Maryland 
    20892-7010, Phone 301-496-9838, FAX 301-496-9839.
    
        Dated: October 26, 1997.
    Lana Skirboll,
    Associate Director for Science Policy, National Institutes of Health.
    [FR Doc. 97-29072 Filed 11-3-97; 8:45 am]
    BILLING CODE 4140-01-P
    
    
    

Document Information

Published:
11/04/1997
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
97-29072
Pages:
59720-59720 (1 pages)
PDF File:
97-29072.pdf